Cellular Quiescence Caused by the Mdm2 Inhibitor Nutlin-3a

Cell Cycle - United States
doi 10.4161/cc.8.22.10121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation

PLoS ONE
Multidisciplinary
2015English

Activation of the P53 Pathway by the MDM2 Inhibitor Nutlin-3a Overcomes BCL2 Overexpression in a Preclinical Model of Diffuse Large B-Cell Lymphoma Associated With T(14;18)(q32;q21)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Fibroid Explants Reveal a Higher Sensitivity Against MDM2-inhibitor Nutlin-3 Than Matching Myometrium

BMC Women's Health
MedicineGynecologyReproductive MedicineObstetrics
2012English

Hyper-Excitability Followed by Functional Quiescence in Neuronal Cells Caused by Insufficient Cellular Energy (ICE): Treatable by Enhancing the Alternative Cellular Energy (ACE) Pathway

World Journal of Neuroscience
2017English

Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2

PLoS ONE
Multidisciplinary
2014English

HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the P53-Reactivating Drugs Nutlin-3 and RITA

Cancer Research
Cancer ResearchOncology
2009English

The Pharmacodynamics of the P53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2014English

Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Clinical Cancer Research
Cancer ResearchOncology
2018English

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy